The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kanzer Steve H since 2006.
The trader's CIK number is 1076653.
At the time of the last reporting, Kanzer Steve H was the Chief Executive Offi of Synthetic Biologics, Inc.. (stock ticker symbol SYN).
Also see all insider trading activities at Synthetic Biologics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | SYN | 0 | $0 | 5,003,025 | $7,154,325 | 0 | $0 |
2008 | SYN | 7,136,380 | $44,400 | 0 | $0 | 0 | $0 |
2007 | SYN | 35,843,395 | $6,211,305 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | DOR | 212,766 | $100,000 | 0 | $0 | 0 | $0 |
2006 | DOR | 0 | $0 | 0 | $0 | 250,000 | $50,000 |
1. Synthetic Biologics, Inc. (SYN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-04-30 | SYN | Sale | 5,003,025 | 1.43 | 7,154,325 |
2008-04-11 | PP | Buy | 50,000 | .89 | 44,400 |
2006-10-31 | PP | Buy | 7,086,380 | .00 | 0 |
2007-07-25 | PP | Buy | 14,300 | 7.19 | 102,845 |
2006-10-31 | PP | Buy | 7,086,379 | .00 | 0 |
2007-07-24 | PP | Buy | 8,000 | 7.12 | 57,000 |
2006-10-31 | PP | Buy | 7,086,379 | .00 | 0 |
2007-07-23 | PP | Buy | 29,700 | 6.74 | 200,296 |
2006-10-31 | PP | Buy | 7,086,379 | .00 | 0 |
2007-07-17 | PP | Buy | 25,000 | 5.27 | 131,750 |
2006-10-31 | PP | Buy | 7,086,379 | .00 | 0 |
2007-07-16 | PP | Buy | 81,000 | 4.78 | 387,180 |
2006-11-02 | PP | Buy | 7,086,379 | .67 | 4,747,873 |
2007-05-11 | PPEX | Buy | 26,500 | 5.23 | 138,595 |
2007-04-16 | PPXP | Buy | 161,000 | 1.93 | 310,730 |
2007-04-17 | PPXP | Buy | 66,000 | 2.05 | 135,036 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-02-09 | DOR | Buy | 212,766 | .47 | 100,000 |
2006-01-20 | DOR | Option Ex | 250,000 | .20 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kanzer Steve H (Chief Executive Offi of Synthetic Biologics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.